O'Rourke & Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
O'Rourke & Company's BMY Position: Q3 2026 in Review
O'Rourke & Company reduced its Bristol-Myers Squibb (BMY) stake by 4.2% in Q3 2026, selling an estimated $32.2K and leaving 11,691 shares worth $730K. The position accounts for 0.25% of the portfolio, ranked #89.
O'Rourke & Company first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.14M in Q4 2021. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- O'Rourke & Company held 11,691 shares of Bristol-Myers Squibb worth $730K as of Q3 2026.
- O'Rourke & Company sold 510 Bristol-Myers Squibb shares in Q3 2026, an estimated $32.2K.
- Bristol-Myers Squibb made up 0.25% of O'Rourke & Company's portfolio in Q3 2026, its #89 holding.
- O'Rourke & Company first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
- O'Rourke & Company's Bristol-Myers Squibb position peaked at $1.14M in Q4 2021.
- 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on O'Rourke & Company's 13F filing for Q3 2026, filed 13 Nov 2026.